Why Transurban Group looks to have a bright future

Transurban Group is a great example of a successful infrastructure enterprise.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Transurban Group (ASX: TCL) is solely involved in development, operation and maintenance of toll roads in Australia and the United States. Toll roads have high barriers to entry, so that competition does not become a risk for their performance as money making operations. This means that they will generate strong cashflows for a very long time. Once a toll road has been constructed, relatively little extra capital is required to maintain that road.

Economic Background

A toll road operator is a "price maker," unlike a company such as Fortescue Metals Group Limited (ASX: FMG), which is a "price taker." A price maker does not suffer the vagaries of adverse price changes. Rather, a price maker can benefit by increasing prices as the consumer price index changes. Price increases, due to consumer price rises, mainly drop to the bottom line, as most of the cost of the business was taken during toll road development. Also earnings grow as traffic volume increases. Furthermore, well planned upgrades, including lane additions, can generate excess returns.

Transurban's strategy is to diversify its portfolio of toll roads, drive operational efficiencies and upgrade roads as needed. The cost reduction program initiated in June 2008 is progressing well and further savings should negate inflation pressures and see costs remain well contained over the medium term.

Future Prospects

With a portfolio of excellent toll road assets and an experienced management team, Transurban is well positioned for lots of growth potential. This type of enterprise has low risk being a price maker. With a stated dividend of 35 cents for the year ending June 30, the dividend yield 4.7%. Forecast dividend yield is 5.2% for 2015; and 5.6% for 2016.

Therefore, I would be happy to buy at current prices for safety and increasing income returns for the long term.

Motley Fool contributor Chris Koenig does not have shares in the companies mentioned.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »